12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Stemline amends IPO

Stemline Therapeutics Inc., New York, N.Y.
Business: Cancer
Date announced: 10/22/12
Type: IPO
To be raised: Up to $25.1 million
Shares: 1.8...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >